Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Sum of received funds = a core asset?
4
Feb 23, 2011 10:31AM
9
Feb 23, 2011 11:03AM
1
Feb 23, 2011 11:22AM
3
Feb 23, 2011 03:07PM

So based on your numbers (quite viable based on prior assertations by the BOD) maybe $1.50 target worth per share - $600M potential income.

Apple has $50B in cash AND now have the "majority vote" BOD rule. Now there's a Headline we could have had: "PTSC beats APPLE to introduce new director algorithm."

Wouldn't Apple's legal department like to have some fun with competitors?

Simple deal - AAPL buys PTSC for $600M. Everyone's happy except maybe TPL. Our BOD cashes in their options but that's OK 'cos we all got $1,50.

Does Apple infringe MMP? If so, maybe $1.75 a share.

Share
New Message
Please login to post a reply